FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2976243756> ?p ?o ?g. }

• W2976243756 abstract "Purpose: Endoscopic dextranomer/hyaluronic acid (Dx/HA) injection is a common treatment for vesicoureteral reflux (VUR) with excellent reported short-term clinical success rates. Long-term outcomes are less well-defined. We assessed long-term outcomes and parental satisfaction after Dx/HA injection for primary VUR with >5-year follow-up. Materials and Methods: Families of all patients who underwent Dx/HA injection for primary VUR at our institution between 2008 and 2012 were contacted for telephone interview. Data collected by phone included parental satisfaction and presence and severity of UTIs pre-operatively and post-operatively. Patient demographics, radiographic VUR data, need for secondary surgery, and surgical indications were obtained through chart review. Results: Five hundred and seventy-five patients underwent Dx/HA injection for primary VUR between 2008 and 2012. Ninety-nine (17.2%) of these patients' parents were successfully contacted and interviewed. Median follow-up time from surgery to survey was 8.4 (IQR 6.8-9.6) years. Secondary surgery was performed in 13/99 (13.1%), most commonly repeat Dx/HA injection. Seven patients (7.1%) underwent secondary Dx/HA injection for persistent VUR without UTIs at a median of 0.35 (IQR 0.33-0.77) years post-operatively. Five patients (5.1%) underwent Dx/HA injection (n = 3) or ureteral reimplantation (n = 2) for VUR with febrile UTIs (fUTIs) at a median of 2.2 (IQR 1.3-5.1) years. One patient had ureteral reimplantation for symptomatic obstruction 2.8 years after initial surgery. Only 3/99 (3.0%) required open or laparoscopic surgery after Dx/HA injection. Eighty-three families (84.7%) reported ≥1 fUTIs pre-operatively. Of these, only 9/83 (10.8%) reported fUTIs post-operatively, for an overall clinical success rate of 89.2%. Clinical success was 93.1% in patients whose pre-operative fUTIs were treated outpatient and 80.0% in those hospitalized at least once for fUTI treatment pre-operatively. Ninety-four percent of parents were highly satisfied, 2.4% partially satisfied, and 3.5% dissatisfied. Conclusions: Endoscopic injection with Dx/HA for primary VUR appears to have good long-term clinical success rates and high parental satisfaction, mirroring our previously reported short-term results. Post-operative ureteral obstruction is rare but may occur years post-operatively, justifying initial sonographic surveillance, and repeat imaging in symptomatic patients." @default.
• W2976243756 created "2019-10-03" @default.
• W2976243756 creator A5005396200 @default.
• W2976243756 creator A5007553722 @default.
• W2976243756 creator A5013776666 @default.
• W2976243756 creator A5013925783 @default.
• W2976243756 creator A5018773233 @default.
• W2976243756 creator A5021781507 @default.
• W2976243756 creator A5025465454 @default.
• W2976243756 creator A5041371344 @default.
• W2976243756 creator A5073271168 @default.
• W2976243756 creator A5075707248 @default.
• W2976243756 date "2019-09-27" @default.
• W2976243756 modified "2023-10-18" @default.
• W2976243756 title "Long-Term Clinical Outcomes and Parental Satisfaction After Dextranomer/Hyaluronic Acid (Dx/HA) Injection for Primary Vesicoureteral Reflux" @default.
• W2976243756 cites W1485271732 @default.
• W2976243756 cites W1975224183 @default.
• W2976243756 cites W1979938425 @default.
• W2976243756 cites W1990318701 @default.
• W2976243756 cites W2004988159 @default.
• W2976243756 cites W2008782871 @default.
• W2976243756 cites W2008882410 @default.
• W2976243756 cites W2015275264 @default.
• W2976243756 cites W2019286381 @default.
• W2976243756 cites W2022145727 @default.
• W2976243756 cites W2024500384 @default.
• W2976243756 cites W2025743025 @default.
• W2976243756 cites W2042630900 @default.
• W2976243756 cites W2051628593 @default.
• W2976243756 cites W2056988366 @default.
• W2976243756 cites W2072063850 @default.
• W2976243756 cites W2094725628 @default.
• W2976243756 cites W2095918352 @default.
• W2976243756 cites W2097964382 @default.
• W2976243756 cites W2104078061 @default.
• W2976243756 cites W2113752024 @default.
• W2976243756 cites W2118692333 @default.
• W2976243756 cites W2133766506 @default.
• W2976243756 cites W2140171932 @default.
• W2976243756 cites W2143867892 @default.
• W2976243756 cites W2149801436 @default.
• W2976243756 cites W2152170936 @default.
• W2976243756 cites W2153592684 @default.
• W2976243756 cites W2167147524 @default.
• W2976243756 cites W2282385047 @default.
• W2976243756 cites W2346582043 @default.
• W2976243756 cites W2349887275 @default.
• W2976243756 cites W2587983903 @default.
• W2976243756 cites W2604512051 @default.
• W2976243756 cites W2623218889 @default.
• W2976243756 cites W2623453380 @default.
• W2976243756 cites W2757468746 @default.
• W2976243756 cites W2792664691 @default.
• W2976243756 cites W2804209160 @default.
• W2976243756 cites W3213299891 @default.
• W2976243756 cites W4243334900 @default.
• W2976243756 cites W4249805514 @default.
• W2976243756 cites W4361745362 @default.
• W2976243756 doi "https://doi.org/10.3389/fped.2019.00392" @default.
• W2976243756 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6776605" @default.
• W2976243756 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31612121" @default.
• W2976243756 hasPublicationYear "2019" @default.
• W2976243756 type Work @default.
• W2976243756 sameAs 2976243756 @default.
• W2976243756 citedByCount "10" @default.
• W2976243756 countsByYear W29762437562020 @default.
• W2976243756 countsByYear W29762437562021 @default.
• W2976243756 countsByYear W29762437562023 @default.
• W2976243756 crossrefType "journal-article" @default.
• W2976243756 hasAuthorship W2976243756A5005396200 @default.
• W2976243756 hasAuthorship W2976243756A5007553722 @default.
• W2976243756 hasAuthorship W2976243756A5013776666 @default.
• W2976243756 hasAuthorship W2976243756A5013925783 @default.
• W2976243756 hasAuthorship W2976243756A5018773233 @default.
• W2976243756 hasAuthorship W2976243756A5021781507 @default.
• W2976243756 hasAuthorship W2976243756A5025465454 @default.
• W2976243756 hasAuthorship W2976243756A5041371344 @default.
• W2976243756 hasAuthorship W2976243756A5073271168 @default.
• W2976243756 hasAuthorship W2976243756A5075707248 @default.
• W2976243756 hasBestOaLocation W29762437561 @default.
• W2976243756 hasConcept C126322002 @default.
• W2976243756 hasConcept C141071460 @default.
• W2976243756 hasConcept C144024400 @default.
• W2976243756 hasConcept C149923435 @default.
• W2976243756 hasConcept C187212893 @default.
• W2976243756 hasConcept C2777609623 @default.
• W2976243756 hasConcept C2779134260 @default.
• W2976243756 hasConcept C2780084366 @default.
• W2976243756 hasConcept C43270747 @default.
• W2976243756 hasConcept C71924100 @default.
• W2976243756 hasConceptScore W2976243756C126322002 @default.
• W2976243756 hasConceptScore W2976243756C141071460 @default.
• W2976243756 hasConceptScore W2976243756C144024400 @default.
• W2976243756 hasConceptScore W2976243756C149923435 @default.
• W2976243756 hasConceptScore W2976243756C187212893 @default.
• W2976243756 hasConceptScore W2976243756C2777609623 @default.
• W2976243756 hasConceptScore W2976243756C2779134260 @default.
• W2976243756 hasConceptScore W2976243756C2780084366 @default.
• W2976243756 hasConceptScore W2976243756C43270747 @default.
• W2976243756 hasConceptScore W2976243756C71924100 @default.

• next